INT0142_2B | R Documentation |
Kaplan-Meier digitized data from INT0142, figure 2B (PMID 25349302). A reported sample size of 345 for a primary endpoint of DFS/OS in breast cancer.
INT0142_2B
A data frame of 337 observations and 3 variables:
time | event time (in years) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (tamoxifen, tamoxifen_ofs) | |
Tevaarwerk AJ, Wang M, Zhao F, et al. Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2014; 32: 3948–58.
summary(INT0142_2B)
kmplot(INT0142_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.